155 related articles for article (PubMed ID: 37933113)
21. Metastatic location of extensive stage small-cell lung cancer: implications for thoracic radiation.
Zhang H; Deng L; Wang X; Wang D; Teng F; Yu J
J Cancer Res Clin Oncol; 2019 Oct; 145(10):2605-2612. PubMed ID: 31410604
[TBL] [Abstract][Full Text] [Related]
22. Consolidative thoracic radiotherapy for extensive stage small cell lung cancer.
Zhang X; Yu J; Zhu H; Meng X; Li M; Jiang L; Ding X; Sun X
Oncotarget; 2017 Mar; 8(13):22251-22261. PubMed ID: 28118612
[TBL] [Abstract][Full Text] [Related]
23. Efficacy and safety of anti-PD-1 inhibitor versus anti-PD-L1 inhibitor in first-line treatment of extensive-stage small cell lung cancer: a multicenter retrospective study.
Qin B; Xin L; Liang C; Li L; Song Q; Long Y; Zhang X; Wang D; Shi W; Zhang J; Hu Y; Yang B; Xiong Q
BMC Cancer; 2024 Jan; 24(1):100. PubMed ID: 38233798
[TBL] [Abstract][Full Text] [Related]
24. Thoracic radiotherapy may improve the outcome of extensive stage small cell lung carcinoma patients treated with first-line immunotherapy plus chemotherapy.
Wu JJ; Huang JW; Hsu KH; Huang YH; Chen KC; Tseng JS; Yang TY; Chang GC
Anticancer Drugs; 2022 Nov; 33(10):e842-e849. PubMed ID: 36206101
[TBL] [Abstract][Full Text] [Related]
25. [Thoracic radiation therapy improves the prognosis for patients with extensive stage small-cell lung cancer].
Zhu H; Zhou ZM; Feng QF; Ou GF; Liang J; Zhang XR; Zhang HX; Chen DF; Xiao ZF; Wang LH
Zhonghua Zhong Liu Za Zhi; 2011 Feb; 33(2):142-6. PubMed ID: 21575486
[TBL] [Abstract][Full Text] [Related]
26. First-line atezolizumab/durvalumab plus platinum-etoposide combined with radiotherapy in extensive-stage small-cell lung cancer.
Li L; Yang D; Min Y; Liao A; Zhao J; Jiang L; Dong X; Deng W; Yu H; Yu R; Zhao J; Shi A
BMC Cancer; 2023 Apr; 23(1):318. PubMed ID: 37024843
[TBL] [Abstract][Full Text] [Related]
27. Thoracic radiotherapy (TRT) improved survival in both oligo- and polymetastatic extensive stage small cell lung cancer.
Xu LM; Cheng C; Kang M; Luo J; Gong LL; Pang QS; Wang J; Yuan ZY; Zhao LJ; Wang P
Sci Rep; 2017 Aug; 7(1):9255. PubMed ID: 28835666
[TBL] [Abstract][Full Text] [Related]
28. Development and validation of a nomogram for assessing survival in extensive-stage small-cell lung cancer patients with superior vena cava syndrome referred for thoracic radiotherapy: a comparison of upfront vs. consolidative approaches.
Mei T; Xiu W; Yang X; Tian X; Yu Y; Xu Y; Zhou L; Zhou X; Liu Y; Zou B; Xue J; Ao R; Lu Y; Gong Y
Strahlenther Onkol; 2021 Dec; 197(12):1072-1083. PubMed ID: 33909099
[TBL] [Abstract][Full Text] [Related]
29. Effects of thoracic radiotherapy timing and duration on progression-free survival in limited-stage small cell lung cancer.
Zhao S; Zhou T; Ma S; Zhao Y; Zhan J; Fang W; Yang Y; Hou X; Zhang Z; Chen G; Zhang Y; Huang Y; Zhang L
Cancer Med; 2018 Sep; 7(9):4208-4216. PubMed ID: 30019533
[TBL] [Abstract][Full Text] [Related]
30. Radiation therapy for extensive-stage small-cell lung cancer in the era of immunotherapy.
Tian Y; Ma J; Jing X; Zhai X; Li Y; Guo Z; Yu J; Zhu H
Cancer Lett; 2022 Aug; 541():215719. PubMed ID: 35597478
[TBL] [Abstract][Full Text] [Related]
31. Chemotherapy or chemo-immunotherapy as first-line treatment for extensive-stage small-cell lung cancer: a meta-analysis.
Chen CY; Chen WC; Hung CM; Wei YF
Immunotherapy; 2021 Oct; 13(14):1165-1177. PubMed ID: 34261336
[TBL] [Abstract][Full Text] [Related]
32. Which patients with ES-SCLC are most likely to benefit from more aggressive radiotherapy: A secondary analysis of the Phase III CREST trial.
Slotman BJ; Faivre-Finn C; van Tinteren H; Keijser A; Praag J; Knegjens J; Hatton M; van Dam I; van der Leest A; Reymen B; Stigt J; Haslett K; Tripathi D; Smit EF; Senan S
Lung Cancer; 2017 Jun; 108():150-153. PubMed ID: 28625628
[TBL] [Abstract][Full Text] [Related]
33. Consolidative thoracic radiotherapy in stage IV small cell lung cancer: Selection of patients amongst European IASLC and ESTRO experts.
Putora PM; Glatzer M; De Ruysscher D; Faivre-Finn C; Belderbos J; Besse B; Blackhall F; Califano R; Cappuzzo F; de Marinis F; Dziadiuszko R; Felip E; Früh M; Garrido P; Le Pechoux C; McDonald F; Nestle U; Novello S; Brien MO; Paz Ares L; Peeters S; Pöttgen C; Ramella S; Reck M; Troost EGC; Van Houtte P; Westeel V; Widder J; Mornex F; Slotman BJ
Radiother Oncol; 2019 Jun; 135():74-77. PubMed ID: 31015173
[TBL] [Abstract][Full Text] [Related]
34. A retrospective real-world experience of immunotherapy in patients with extensive stage small-cell lung cancer.
Qiu G; Wang F; Xie X; Liu T; Zeng C; Chen Z; Zhou M; Deng H; Yang Y; Lin X; Xie Z; Sun G; Zhou C; Liu M
Cancer Med; 2023 Jul; 12(14):14881-14891. PubMed ID: 37462138
[TBL] [Abstract][Full Text] [Related]
35. The role of thoracic consolidative radiotherapy in the setting of immunotherapy in extensive stage small cell lung cancer.
Verma S; Young S; Louie AV; Palma D; Breadner D
Ther Adv Med Oncol; 2023; 15():17588359231192399. PubMed ID: 37655208
[TBL] [Abstract][Full Text] [Related]
36. Assessing treatment outcomes of chemoimmunotherapy in extensive-stage small cell lung cancer: an integrated clinical and radiomics approach.
Zhao J; He Y; Yang X; Tian P; Zeng L; Huang K; Zhao J; Zhou J; Zhu Y; Wang Q; Chen M; Li W; Gao Y; Zhang Y; Xia Y
J Immunother Cancer; 2023 Sep; 11(9):. PubMed ID: 37730276
[TBL] [Abstract][Full Text] [Related]
37. Radiotherapy for extensive-stage small-cell lung cancer in the immunotherapy era.
Li H; Zhao Y; Ma T; Shao H; Wang T; Jin S; Liu Z
Front Immunol; 2023; 14():1132482. PubMed ID: 37701437
[TBL] [Abstract][Full Text] [Related]
38. Timing of thoracic radiotherapy in limited stage small cell lung cancer: results of early versus late irradiation from a single institution in Turkey.
Bayman E; Etiz D; Akcay M; Ak G
Asian Pac J Cancer Prev; 2014; 15(15):6263-7. PubMed ID: 25124609
[TBL] [Abstract][Full Text] [Related]
39. Dose escalation and associated predictors of survival with consolidative thoracic radiotherapy in extensive stage small cell lung cancer (SCLC): A National Cancer Database (NCDB) propensity-matched analysis.
Hasan S; Renz P; Turrisi A; Colonias A; Finley G; Wegner RE
Lung Cancer; 2018 Oct; 124():283-290. PubMed ID: 30268474
[TBL] [Abstract][Full Text] [Related]
40. Treatment patterns and clinical outcomes of extensive stage small cell lung cancer (SCLC) in the real-world evidence ESME cohort before the era of immunotherapy.
Valette CA; Filleron T; Debieuvre D; Lena H; Pérol M; Chouaid C; Simon G; Quantin X; Girard N
Respir Med Res; 2023 Nov; 84():101012. PubMed ID: 37307617
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
